TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,718,000 | -3.4% | 288,057 | -0.8% | 0.03% | 0.0% |
| Q2 2021 | $4,886,000 | -7.8% | 290,307 | 0.0% | 0.03% | -13.9% |
| Q1 2021 | $5,301,000 | +0.6% | 290,307 | +0.2% | 0.04% | -5.3% |
| Q4 2020 | $5,272,000 | -15.7% | 289,657 | -17.3% | 0.04% | -22.4% |
| Q3 2020 | $6,251,000 | -0.5% | 350,412 | 0.0% | 0.05% | -3.9% |
| Q2 2020 | $6,283,000 | +18.1% | 350,412 | 0.0% | 0.05% | +8.5% |
| Q1 2020 | $5,319,000 | -23.0% | 350,412 | +0.1% | 0.05% | +4.4% |
| Q4 2019 | $6,910,000 | +15.1% | 350,212 | +0.3% | 0.04% | +12.5% |
| Q3 2019 | $6,005,000 | -2.7% | 349,112 | +0.1% | 0.04% | 0.0% |
| Q2 2019 | $6,172,000 | -12.8% | 348,712 | +0.4% | 0.04% | -9.1% |
| Q1 2019 | $7,075,000 | – | 347,312 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |